A new preprint study suggests that Moderna’s COVID-19 vaccine may be significantly more effective against symptomatic disease from the delta variant compared to Pfizer-BioNTech’s vaccine, while the ...
NEW YORK, N.Y. — Pfizer announced Wednesday that data shows a third dose of its COVID-19 vaccine can “strongly” boost protection against the highly transmissible delta variant. The pharmaceutical and ...
A third dose of the Pfizer/BioNTech COVID-19 vaccine can "strongly" boost protection against the delta variant -- beyond the protection afforded by the standard two doses, suggests new data released ...
Pfizer is about to seek U.S. authorization for a third dose of its COVID-19 vaccine, saying Thursday that another shot within 12 months could dramatically boost immunity and maybe help ward off the ...
Moderna on Tuesday released preliminary data indicating its vaccine is likely to hold up against several variants of concern, including the Delta variant, which is predicted to become the dominant ...
Pfizer's CEO is expressing confidence about the efficacy of his company's COVID-19 vaccine against the Delta variant, which was first discovered in India and has America's top scientists sounding the ...
SAN FRANCISCO -- Earlier in the pandemic, experts had hoped if we can get 75% of Americans vaccinated, we can contain the coronavirus. Thursday, we're at just over 50% vaccinated. But 75% is no longer ...
LOS ANGELES (KABC) -- While overall COVID-19 rates remain relatively low in Southern California amid continuing vaccination efforts, officials are increasingly worried about a growing threat from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback